Philippine FDA Approves Znth CR After Clinical Studies
MANILA, REPUBLIC OF THE PHILIPPINES, September 21, 2021 /EINPresswire.com/ – 2 series of clinical studies completed in the Philippines
First-round human trial: 95% recovery rate
We viewed COVID-19 as a serious threat to humanity. Znth CR Medical Supplies,
with its partners in North America and South Korea, conducted its first clinical trial in the Philippines from May 2020. Znth CR oral tablets have been administered to 21 patients ranging from asymptomatic to acute condition. Within 2 to 7 days, all patients, with one exception, were able to fully recover from the symptoms of COVID-19 (1 patient died from previous heart disease). In addition, all patients were able to test negative for COVID-19 through PCR testing.
With a 95% recovery rate, Znth CR Medical Supply agreed to conduct an additional clinical trial on only COVID-19 patients who were in the severe to acute stages. All asymptomatic to moderate cases were removed.
Second-round human trial: 92% recovery rate
Znth CR Medical Supply conducted its second clinical trial in COVID-19 patients with severe to acute illnesses in the Philippines with the help of 4 regional Covid hospitals and Covid certified doctors.
All 25 patients who participated, except one patient, had co-morbidities or previous medical problems, ranging from diabetes, asthma and hypertension to emphysema. In addition, all were on oxygen. Patients recovered in an average of 6 days (2 were disqualified for taking other medications). The mean age of the 23 patients was 46.6 years; the youngest is 7 years old, the oldest 85 years old. The trial consisted of 12 women and 11 men. All patients have graciously agreed to publish the radiology reports as well as the results of the PCR tests which can be viewed at www.znthcr.com.
Philippines FDA approval of Znth CR as a drug
In February 2020, we were approved as a nutritional supplement by the Philippine FDA (license number: 3000005876821).
In August 2021, we were approved by the Philippine FDA as a drug to treat COVID-19 (license number: CDRR-RIVA-DI / E / W-87276).
And after? 100% of proceeds go to non-profit charities
We all want to save humanity. 100% of the profits will go to charities selected by our consumers. Currently, Znth CR Medical Supply is negotiating contracts with more than 10 countries. For individuals, Znth CR can be purchased from our website at www.znthcr.com.
Joseph A Ramos
Znth CR Medical Supplies
write us here